Epithelial to mesenchymal plasticity: role in cancer progression
Epithelial-mesenchymal transition (EMT) is a dynamic process by which the cells transdifferentiate into two or more somatic states. The metastatic spread begins with tumor cells disseminated from the primary tumor via intravasation, hematogenous transit and extravasation to reach the distant organs...
Main Authors: | Remya Raja, Akhilesh Pandey, Prashant Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2020-01-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/25/5/10.2741/4837 |
Similar Items
-
Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
by: Santhasiri Orrapin, et al.
Published: (2022-07-01) -
CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial–mesenchymal transition
by: Bin Li, et al.
Published: (2019-10-01) -
Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers
by: William L. Harryman, et al.
Published: (2022-03-01) -
TGF-β1-induced epithelial–mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin
by: Hui Wang, et al.
Published: (2017-11-01) -
Heterogeneity of expression of epithelial-mesenchymal transition (EMT) markers in melanocytes and melanoma cell lines
by: Ji Eun eKim, et al.
Published: (2013-05-01)